secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0000950170-24-127644
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Board member Anne Altmeyer adopts 10b5-1 plan to sell up to 2,452 shares of CRBP common stock
--------------------------------------------------------------------------------

- Anne Altmeyer, Ph.D., board member, adopted Rule 10b5-1 plan on Nov 14, 2024.
- Plan allows sale of up to 2,452 shares of common stock.
- Sales may begin on February 13, 2025; plan terminates December 31, 2025.
- Plan is intended to satisfy affirmative defense under Rule 10b5-1(c).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024127644/0000950170-24-127644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024127644/crbp-20241115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-127644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer